[Remote] UI/UX Designer at Elegen

Remote

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

SaaS, Design ServicesIndustries

Requirements

Candidates must possess B2-C1 level English proficiency and at least 2 years of experience in application design for web and mobile platforms. A strong command of Ukrainian for internal communication, proficiency in Figma, web design, product design, and design systems are essential. Excellent knowledge of design principles, typography, and composition, along with emotional intelligence and a sense of humor, are also required. Experience in designing SaaS products and Webflow experience are considered a plus.

Responsibilities

The UI/UX Designer will be responsible for working on product design, considering client feedback and product type. This role involves direct communication with clients to understand priorities and discuss design decisions.

Skills

Figma

Web design

Product design

Design systems

Application design

SaaS product design

Webflow

Design frameworks

Typography

Composition

Emotional intelligence

English B2-C1

Ukrainian

Elegen

Custom DNA synthesis for biotech applications

About Elegen

Elegen focuses on improving the process of manufacturing synthetic DNA to meet the needs of the bioeconomy. The company provides custom DNA synthesis services to researchers, biotech companies, and pharmaceutical firms that require high-quality and complex synthetic DNA for various applications, including biomanufacturing and mRNA-based treatments. Elegen uses advanced technologies to ensure fast turnaround times and high accuracy in DNA synthesis, which are essential for its clients' projects. Unlike its competitors, Elegen not only streamlines traditional DNA manufacturing workflows but also enables the production of valuable biologics and therapeutics. The company's goal is to support the development of next-generation mRNA medicines and other advanced therapeutics by providing reliable and efficient DNA solutions.

San Carlos, CaliforniaHeadquarters

2017Year Founded

$34MTotal Funding

SERIES_BCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Short Term Disability

Long Term Disability

Parental Leave

Commuter Benefits

Fitness Allowance

Learning Allowance

Risks

Increased competition from companies like Twist Bioscience in DNA synthesis capabilities.

Potential intellectual property disputes could impact Elegen's proprietary technologies.

Dependence on key partnerships, like GSK, could affect market position if dissolved.

Differentiation

Elegen's ENFINIA™ DNA offers rapid synthesis of highly complex DNA in 10 days.

The company provides cell-free DNA production, reducing contamination risks and improving efficiency.

Elegen's Early Access Program allows clients early access to high-complexity DNA breakthroughs.

Upsides

Elegen raised $35M to expand its ENFINIA™ DNA product line for clinical development.

Collaboration with GSK enhances Elegen's cell-free DNA technology for vaccines and medicines.

Elegen's ability to synthesize complex DNA sequences gives it a competitive market edge.

Land your dream remote job 3x faster with AI

Try Jobo Free